Clinical trials are an important step in this process. We’re working with patients every step of the way to bring new therapeutic options to those living with cancer. Blue Note’s apps are first of their kind in the field of cancer care, and once approved, they will be available only through a prescription from your medical provider. Explore our Clinical Trials today to join our mission and help advance the future of cancer care.
Clinical trials are research studies conducted to determine the safety and effectiveness of new or existing interventions, such as a new drug, medical device or counseling program. They are an integral part of the advancement of new therapies to shape the treatment landscape.
Learn moreBlue Note’s clinical trials are designed to evaluate the safety and effectiveness of digital therapeutics in alleviating the distress caused by cancer - from diagnosis all the way through to survivorship.
Learn moreBlue Note upholds the highest ethical standards as we seek to ease the burden of cancer for all patients through the development of prescription digital therapeutics.
Learn moreBlue Note understands the decision to join a clinical trial is not always easy. Becoming aware of the potential benefits that trials may offer can help a patient to make this decision.
Learn moreAll clinical trials have unique eligibility criteria. A pre-screening conducted by the study doctor and his or her team will be necessary to determine if a study is the right fit for you.
The data and information you provide electronically during a Blue Note trial is secure and will only be shared with a clinician as needed for safety purposes.
Clinical trials must comply with privacy laws. In the U.S., the main federal privacy law is known as the Health Insurance Portability and Accountability Act or HIPAA.
Your rights as a study participant are important. During informed consent, your study doctor and his or her team will explain to you the following:
Every patient is different and has a unique perspective to offer. By being a part of a clinical trial, patients can provide their own input, experience and feedback.
While every patient is different, they are also not alone. In a clinical trial, you have the opportunity to become part of a community and understand how your input as well as the collective input will help advance new therapies.
Robust clinical trials benefit from the participation of diverse communities and individuals to ensure insights and findings truly represent the population of all people living with cancer.
Most clinical trials are designed to evaluate investigational therapeutics or interventions. Participating in a trial may give you access to a treatment which would otherwise not have been available.
Blue Note’s digital therapeutics – prescription-only apps that you can access on your laptop or mobile device – are being created to alleviate the distress caused by cancer, from diagnosis all the way through to survivorship.
Across all stages of cancer, our trials are intended to represent the diversity of U.S. communities. This will help us better understand various populations and further target our treatments to meet the unique needs of all patients living with cancer.
View current trialsTo prioritize the rights, safety and well-being of all study participants
To design trials to reach diverse communities
To ensure data privacy & safety
To enable transparency of study findings once available